Catapharma (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.85 M
- Company Age 38 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.55 Cr
- Revenue Growth 120.68%
- Profit Growth 259.67%
- Ebitda 283.73%
- Net Worth 59.36%
- Total Assets -7.79%
About Catapharma (India)
Catapharma (India) Pvt Ltd (CIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 October 1986 and has a history of 38 years and three months. Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.85 M.
The company currently has active open charges totaling ₹4.55 Cr.
Shrikant Karwa and Manju Karwa serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U99999MH1986PTC041424
- Company No.
041424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Catapharma (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrikant Karwa  | Managing Director | 29-Oct-1986 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manju Karwa | Director | 18-Feb-2021 | Current |
Financial Performance of Catapharma (India).
Catapharma (India) Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 120.68% increase. The company also saw a substantial improvement in profitability, with a 259.67% increase in profit. The company's net worth Soared by an impressive increase of 59.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Catapharma (India)?
In 2023, Catapharma (India) had a public holding of 76.39%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Catapharma Chemicals Private LimitedShrikant Karwa is a mutual person
- Mdb Chemicals (India) Private Limited
Shrikant Karwa is a mutual person
Catapro Pharmalab Private LimitedShrikant Karwa and Manju Karwa are mutual person
- Recat Digital Solutions Private Limited
Shrikant Karwa is a mutual person
- Dr. Shrikant Karwa Foundation
Shrikant Karwa and Manju Karwa are mutual person
- Sinnar Enviro Foundation
Shrikant Karwa is a mutual person
Charges (Loans)
₹45.50 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 2.45 Cr
- Others : 2.00 Cr
- Dena Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2021 | Others | ₹2.00 Cr | Open |
| 23 Dec 1994 | Bank Of India | ₹2.45 Cr | Open |
| 27 Jun 1994 | Dena Bank | ₹1.00 M | Open |
How Many Employees Work at Catapharma (India)?
Unlock and access historical data on people associated with Catapharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Catapharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catapharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
